Swiss-listed Israeli medtech firm SHL Telemedicine has said that it is considering a dual-listing on another stock exchange. In a statement, it said that the plan intended “to expand investors’ access to SHL’s international activity” and to support the company’s strategy to expand the use of its SmartHeart technology in the US. The company develops…
Home Healthcare Markets International Business Switzerland: SHL Telemedicine considers secondary listing